Survey of patient and physician awareness and values to the diagnosis and treatment of reduced kidney function (chronic kidney disease) in patients with high blood sugar level (type 2 diabetes) (AWARE-CKD in T2D) (AWARE-CKD)
In this survey study, researchers want to find out more about how physicians are treating patients diagnosed with reduced kidney function (chronic kidney disease, CKD) and high blood sugar level (type 2 diabetes); what physicians know about the different treatment options available; and how they use this knowledge to treat their patients successfully. Additionally, researchers want to gather information about patient's awareness of their disease and which criteria they consider important for their treatment of the disease.
The study will survey a total of 150 patients with type 2 diabetes: 50 patients with mild CKD; 50 patients with moderate CKD; and 50 patients with severe CKD. Patients eligible for this study can be male or female and should be at least 18 years old. In addition, a total of 150 physicians will be surveyed. Physicians eligible for this study may be general practitioners, endocrinologist, or nephrologists.
- For patient cohort: --- Diagnosis of type 2 diabetes --- eGFR < 60 ml/min per 1.73 m2 (measured within the last year) OR eGFR ≥ 60 ml/min per 1.73 m2 and uACR ≥ 2 (measured within the last year) --- No documented non-diabetic etiology for renal disease - For physician cohort: --- Licensed general practitioner, endocrinologist or nephrologist --- Currently providing care for patients with chronic kidney disease and type 2 diabetes
- Patients with chronic kidney disease and type 2 diabetes who are physicians - Physicians with chronic kidney disease and type 2 diabetes
Many Locations, Canada
E-mail: [email protected]
Phone: (+)1-888-84 22937
Awareness of diagnosis and treatment of chronic kidney disease in patients with type 2 diabetes